Compare FMC Corp (FMC) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Nomura Holdings Inc — how do they compare? FMC Corp trades at $8.5 (market cap $1.39B), while Nomura Holdings Inc trades at $9.48 (market cap $27.55B). The key difference: Nomura Holdings Inc is far larger — about 19.8× FMC Corp's market cap, and FMC Corp pays the higher dividend (3.59%). Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Nomura Holdings Inc for 55 Days on average.
| FMC | NMR | |
|---|---|---|
Market Cap | $1.39B | $27.55B |
Volume | 4,145,979 | 782,470 |
Sector | Basic Materials | Financials |
52-Week High | $30.63 | $10.86 |
52-Week Low | $8.44 | $6.73 |
Typical Hold Time | 68 Days | 55 Days |
Enterprise Value | $5.19B | $38.54T |
Dividend Yield | 3.59% | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (NYSE: FMC) trades at $8.695, down 4.35% today, reflecting ongoing challenges in the agricultural chemicals sector. The stock shows bearish technical signals with mixed earnings performance - beating Q1 and Q2 2026 estimates but missing Q4 2025. Fundamentally, the company faces significant headwinds with a net income margin of -84.83% and negative ROE of -91.47%, though valuation metrics like P/S of 0.34 and P/B of 0.85 suggest potential undervaluation. Recent developments include regulatory submissions for new herbicides in Brazil and a minority equity investment from Tessenderlo Group.
The investment outlook remains cautious despite analyst consensus pointing to 68% upside potential with a $14.60 price target. While aggressive deleveraging efforts and new product pipelines offer potential catalysts, substantial earnings losses, volatile cash flows, and high debt levels present significant risks. The agricultural sector's cyclical nature and pricing pressures require careful monitoring of the company's turnaround execution and market conditions.
Nomura Holdings (NMR) trades at $9.53, down 2.56% today amid bearish technical signals. The stock shows mixed fundamentals with strong revenue growth to $1.66T in 2025 and net income margin of 20.4%, but recent earnings misses and negative operating cash flow raise concerns. Valuation appears reasonable with P/E of 11.33 and P/B of 1.15. Analyst sentiment is cautious with 67% hold ratings despite recent Zacks strong buy recommendations.
The outlook remains balanced - attractive valuation and revenue growth potential are offset by cash flow challenges and technical weakness. Key risks include Japan's fiscal policy impacts on bond markets and sustained negative operating cash flow. Investors should weigh the discounted valuation against execution risks in the current macroeconomic environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
